Page 31 - SPEMD_67-1

rev port estomatol med dent cir maxilofac . 2026;67(1):21-26 25

There is still debate in the literature regarding the ideal tech- orcid
nique that combines preservation of anatomical structures
with adherence to oncological principles. The main reported Ivana de Sousa Brandão 0000-0002-6380-6648
approaches are standard parotidectomy, facelift, transcutane- João Vitor Freitas da Silva 0009-0001-5595-6232
2
ous incisions, and transoral incisions. Recurrence rates after Filipe Nobre Chaves 0000-0001-6345-8156
surgery or treatment of APG tumors are low, even in cases of Marcelo Bonifácio da Silva Sampieri 0000-0001-7942-6642
malignancy, ranging from zero to 9%. 23
In the present case, factors such as the patient’s age and the Denise Hélen Imaculada Pereira de Oliveira 0000-0001-6020-2374
lesion’s early diagnosis, location, and size allowed for a more
conservative treatment using the transoral approach, which references
represents a minimally invasive, anatomically direct technique
that provides adequate surgical access without the need for 1. Frommer J. The human accessory parotid gland: its
extensive cervicofacial incisions or superficial parotidectomy. incidence, nature, and significance. Oral Surg Oral Med Oral
Furthermore, this approach is associated with a lower risk of Pathol. 1977;43:671–6.
aesthetic and functional morbidity, including visible scarring 2. Luksic I, Mamic M, Suton P. Management of accessory parotid
and potential facial nerve injury, while offering a favorable risk– gland tumours: 32- year experience from a single institution
benefit profile in the management of APG tumors. 24 and review of the literature. Int J Oral Maxillofac Surg.
2019;48:1145–52.
Although conventional parotidectomy has been reported 3. Rosa MA, Łazarz DP, Pękala JR, Skinningsrud B, Lauritzen SS,
as the preferred approach for the management of benign le- Solewski B, et al. The accessory parotid gland and its clinical
sions in the APG due to its wide exposure and easy access to significance. J Craniofac Surg. 2020;31:856-60.
4
the lateral lobe, the transoral approach offers notable advan- 4. Pasick LJ, Tong JY, Benito DA, Thakkar P, Goodman JF, Joshi AS.
tages, including shorter operative time, smaller incision, and Surgical management and outcomes of accessory parotid
greater cosmetic satisfaction, with no significant differences gland neoplasms: a systematic review. Am J Otolaryngol.
2020;41:102610.
in the incidence of facial nerve paresis or Frey’s syndrome. 25 5. Newberry TR, Kaufmann CR, Miller FR. Review of accessory
After seven years of follow-up, the patient appears to have parotid gland tumors: Pathologic incidence and surgical
had very satisfactory healing and no clinical signs of compli- management. Am J Otolaryngol. 2014;35:48-52.
cations or recurrence. 6. Nemecek JR, Marzek PA, Young VL. Diagnosis and treatment of
accessory parotid gland masses. Ann Plast Surg. 1994;33:75–9.
7. Eveson JW, Kusafuka K, Stenman G, Nagao T. Pleomorphic
Conflict of interest adenoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D
editors. World Health Organization Classification of Tumours:
Pathology & Genetics – Head and Neck Tumours. Geneva:
The authors have no conflicts of interest to declare. WHO Press, 2005. p. 254–58. Available from: https://screening.
iarc.fr/doc/BB9.pdf.
8. Andreasen S, Therkildsen MH, Bjørndal K, Homøe P.
Ethical disclosures Pleomorphic adenoma of the parotid gland 1985–2010: a
Danish nationwide study of incidence, recurrence rate, and
malignant transformation. Head Neck.
Protection of human and animal subjects. The authors 2016;38(Suppl1):E1364-9.
declare that no experiments were performed on humans or 9. Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in
animals for this study. oral and maxillofacial regions: a 23-year retrospective study
of 6982 cases in an eastern Chinese population. Int J Oral
Confidentiality of data. The authors declare that they have
Maxillofac Surg. 2010;39:235–42.
followed their work center protocols on access to patient data 10. Fonseca FP, Carvalho MV, de Almeida OP, Rangel ALCA,
and for its publication. Takizawa MCH, Bueno AG, et al. Clinicopathologic analysis of
493 cases of salivary gland tumors in a Southern Brazilian
Right to privacy and informed consent. The authors have population. Oral Surg Oral Med Oral Pathol Oral Radiol.
obtained the written informed consent of the patients or sub- 2012;114:230–9.
jects mentioned in the article. The corresponding author is in 11. Nóbrega MQR, Lopes LJ, Cardoso RG, Nonaka CFW, de Souza
possession of this document. LB. Minor salivary gland neoplasms: retrospective study of 83
cases. RGO Rev Gaúch Odontol. 2010;58:357–62.
12. Almeslet AS. Pleomorphic adenoma: a systematic review. Int
J Clin Pediatr Dent. 2020;13:284-7.
CRediT authorship contribution statement 13. Sergi B, Limongelli A, Scarano E, Fetoni AR, Paludetti G. Giant
deep lobe parotid gland pleomorphic adenoma involving the
Ivana de Sousa Brandão: Conceptualization, Data curation, parapharyngeal space. Report of three cases and review of
Formal analysis, Methodology, Writing – original draft. João the diagnostic and therapeutic approaches. Acta
Vitor Freitas da Silva: Investigation, Visualization, Writing – Otorhinolaryngol Ital. 2008;28:261-5.
review & editing. Filipe Nobre Chaves: Methodology, Supervi- 14. Toh H, Kodama J, Fukuda J, Rittman B, Mackenzie I. Incidence
sion, Validation. Marcelo Bonifácio da Silva Sampieri: Meth- and histology of human accessory parotid glands. Anat Rec.
1993;236:586-90
odology, Supervision, Validation. Denise Hélen Imaculada
15. Lin DT, Coppit GL, Burkey BB, Netterville JL. Tumors of the
Pereira de Oliveira: Methodology, Project administration, Val- Accessory Lobe of the Parotid Gland: A 10-Year Experience.
idation, Visualization, Writing – review & editing. Laryngoscope. 2004;114:1652-5.